J&J reportedly eyeing Shockwave Medical for takeover
Cardiovascular device maker Shockwave has a marketed C²⁺ IVL catheter for the treatment of severely calcified coronary artery disease.
Cardiovascular device maker Shockwave has a marketed C²⁺ IVL catheter for the treatment of severely calcified coronary artery disease.
In addition to drug discovery deals, NVIDIA also announced partnerships with J&J MedTech and GE Healthcare for genAI in MedTech.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Microsoft and NVIDIA expand collaboration in healthcare innovation
BeiGene spin-out Pi Health raises $30m to uptick cancer trial enrolment
Eli Lilly-backed Zephyr AI secures $111m for precision medicine tech
Tierra raises $11.4 in Series A round for predictive AI protein maker